Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 05, 2023

SELL
$0.39 - $0.71 $273 - $497
-700 Reduced 2.13%
32,153 $13,000
Q4 2022

Jan 30, 2023

SELL
$0.33 - $10.44 $1,381 - $43,712
-4,187 Reduced 11.3%
32,853 $13,000
Q2 2022

Jul 22, 2022

SELL
$1.02 - $1.83 $367 - $658
-360 Reduced 0.96%
37,040 $43,000
Q1 2022

Apr 27, 2022

SELL
$1.06 - $2.1 $1,505 - $2,982
-1,420 Reduced 3.66%
37,400 $53,000
Q4 2021

Jan 26, 2022

SELL
$2.05 - $3.2 $179,538 - $280,256
-87,580 Reduced 69.29%
38,820 $80,000
Q3 2021

Oct 25, 2021

SELL
$2.54 - $4.07 $5,334 - $8,547
-2,100 Reduced 1.63%
126,400 $389,000
Q2 2021

Jul 28, 2021

SELL
$2.57 - $4.85 $2,056 - $3,879
-800 Reduced 0.62%
128,500 $523,000
Q1 2021

Apr 28, 2021

SELL
$1.9 - $2.82 $190 - $282
-100 Reduced 0.08%
129,300 $319,000
Q4 2020

Jan 26, 2021

SELL
$1.15 - $2.4 $5,784 - $12,072
-5,030 Reduced 3.74%
129,400 $276,000
Q3 2020

Oct 26, 2020

SELL
$1.11 - $1.68 $2,886 - $4,368
-2,600 Reduced 1.9%
134,430 $163,000
Q2 2020

Jul 15, 2020

SELL
$1.69 - $4.2 $743 - $1,848
-440 Reduced 0.32%
137,030 $236,000
Q1 2020

Apr 13, 2020

SELL
$1.26 - $3.38 $16,304 - $43,737
-12,940 Reduced 8.6%
137,470 $362,000
Q4 2019

Jan 23, 2020

SELL
$0.86 - $1.44 $60,275 - $100,926
-70,088 Reduced 31.79%
150,410 $202,000
Q3 2019

Oct 22, 2019

SELL
$1.21 - $1.59 $5,420 - $7,123
-4,480 Reduced 1.99%
220,498 $267,000
Q2 2019

Jul 17, 2019

SELL
$1.25 - $3.14 $3,650 - $9,168
-2,920 Reduced 1.28%
224,978 $340,000
Q1 2019

Apr 22, 2019

SELL
$2.79 - $4.09 $97,454 - $142,863
-34,930 Reduced 13.29%
227,898 $675,000
Q4 2018

Jan 23, 2019

SELL
$3.23 - $7.01 $14,535 - $31,545
-4,500 Reduced 1.68%
262,828 $883,000
Q3 2018

Oct 25, 2018

SELL
$6.86 - $9.97 $1,817 - $2,642
-265 Reduced 0.1%
267,328 $1.94 Million
Q2 2018

Jul 23, 2018

SELL
$2.88 - $8.67 $892 - $2,687
-310 Reduced 0.12%
267,593 $1.84 Million
Q1 2018

May 02, 2018

SELL
$2.92 - $3.81 $5,942 - $7,753
-2,035 Reduced 0.75%
267,903 $798,000
Q4 2017

Feb 01, 2018

SELL
$2.99 - $4.85 $53,452 - $86,703
-17,877 Reduced 6.21%
269,938 $829,000
Q3 2017

Oct 30, 2017

BUY
$3.01 - $5.41 $866,323 - $1.56 Million
287,815
287,815 $1.35 Million

Others Institutions Holding VSTM

About Verastem, Inc.


  • Ticker VSTM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 210,000,000
  • Market Cap $1.17B
  • Description
  • Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...
More about VSTM
Track This Portfolio

Track Howland Capital Management LLC Portfolio

Follow Howland Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Howland Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Howland Capital Management LLC with notifications on news.